Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma

Diseases of the Colon and Rectum

Volumn 40, Issue 7, 1997, Pages 785-790

  Bhatavdekar, Jyotsna M ^a   Patel, Devendra D ^a   Ghosh, Nandita ^a   Chikhlikar, Priya R ^a   Trivedi, Trupti I ^a   Suthar, Tejal P ^a   Doctor, Sonali S ^a   Shah, Neelam G ^a   Balar, Damodar B ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

Bcl 2; c Myc; Colorectal cancer; Oncoprotein coexpression; p53; Prognosticator(s)

Indexed keywords

AVIDIN; BIOTIN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; MYC PROTEIN; PROLACTIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MALE; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; CARCINOMA; CELL NUCLEUS; COLONIC NEOPLASMS; CYTOPLASM; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RECTAL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030741462     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02055433     Document Type: Article

References (19)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorogenesis. Cell 1990;61:759-67.
2. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C. Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994;9:3367-70.
3. Flohil CC, Janssen PA, Bosman FT. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon. J Pathol 1996;178:393-7.
4. Yamaguchi A, Ninomiya I, Ishida T, et al. Immunohistochemical detection of c-myc products in colorectal cancer and proliferative cell rate. Oncology 1992;49: 40-4.
5. Roussel M, Saule S, Lagrou C, et al. Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature 1979;281:452-5.
6. Sheiness D, Bishop JM. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J Virol 1979;31:514-21.
7. Starzynska T, Bromley M, Ghosh A, Stern P. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;66:558-62.
8. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of p53 protein: independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994; 86:681-7.
9. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309-20.
10. Morson BC, Sobin LH. International histological classification of tumors. Vol. 15. Geneva: World Health Organization, 1976:56-65.
11. Bhatavdekar JM, Patel DD, Giri DD, et al. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum. Br J Cancer 1992;66:977-80.
12. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. Ofner D, Riehemann K, Maier H, et al. Immunohistochemically detectable Bcl-2 expression in colorectal carcinoma: correlation with tumor stage and patient survival. Br J Cancer 1995;72:981-5.
14. Baretton GB, Diebold J, Christoforis G, et al. Apoptosis and immunohistochemical Bcl-2 expression in colorectal adenomas and carcinomas: aspects of carcinogenesis and prognostic significance. Cancer 1996;77:255-64.
15. Sato K, Miyahara M, Saito T, Kobayashi M. c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur J Cancer 1994;30A:1113-7.
16. Jones DJ, Ghosh AK, Moore M, Schofield PF. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer. Br J Cancer 1987;56:779-83.
17. Grewal H, Guillem JG, Klimstra DS, Cohen AM. p53 nuclear overexpression may not be an independent prognostic marker in early colorectal cancer. Dis Colon Rectum 1995;38:1176-81.
18. Mulder J-W, Baas IO, Polak MM, Goodman SN, Offerhaus GJ. Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 1995;71:1257-62.
19. Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778-84.